sotalol has been researched along with Cardiomyopathy, Hypertrophic in 12 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of sotalol on exercise tolerance and incidence of arrhythmias was studied in 30 patients with hypertrophic cardiomyopathy (HCM)." | 9.07 | Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. ( Poloński, L; Schneeweiss, A; Tendera, M; Wodniecki, J; Wycisk, A, 1993) |
| "The effect of sotalol on exercise tolerance and incidence of arrhythmias was studied in 30 patients with hypertrophic cardiomyopathy (HCM)." | 5.07 | Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. ( Poloński, L; Schneeweiss, A; Tendera, M; Wodniecki, J; Wycisk, A, 1993) |
| "Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol." | 2.38 | Empiric use of amiodarone and sotalol. ( Nora, M; Zipes, DP, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shiohira, S | 1 |
| Kawabata, M | 1 |
| Goya, M | 1 |
| Maeda, S | 1 |
| Sasano, T | 1 |
| Hirao, K | 1 |
| Shimada, YJ | 1 |
| Sato, K | 1 |
| Hanon, S | 1 |
| Schweitzer, P | 1 |
| Jayatilleke, I | 1 |
| Doolan, A | 1 |
| Ingles, J | 1 |
| McGuire, M | 1 |
| Booth, V | 1 |
| Richmond, DR | 1 |
| Semsarian, C | 1 |
| Binder, WD | 1 |
| Fifer, MA | 1 |
| King, ME | 1 |
| Stone, JR | 1 |
| Melacini, P | 1 |
| Maron, BJ | 1 |
| Bobbo, F | 1 |
| Basso, C | 1 |
| Tokajuk, B | 1 |
| Zucchetto, M | 1 |
| Thiene, G | 1 |
| Iliceto, S | 1 |
| Nora, M | 1 |
| Zipes, DP | 1 |
| Grant, SC | 1 |
| Bennett, DH | 1 |
| Tendera, M | 1 |
| Wycisk, A | 1 |
| Schneeweiss, A | 1 |
| Poloński, L | 1 |
| Wodniecki, J | 1 |
| Alessandrini, RS | 1 |
| McPherson, DD | 1 |
| Kadish, AH | 1 |
| Kane, BJ | 1 |
| Goldberger, JJ | 1 |
| Boriani, G | 1 |
| Rapezzi, C | 1 |
| Biffi, M | 1 |
| Branzi, A | 1 |
| Ginestes, J | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
2 reviews available for sotalol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Empiric use of amiodarone and sotalol.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; | 1993 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
1 trial available for sotalol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Double-Blind Method; Exercise | 1993 |
9 other studies available for sotalol and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Exercise-induced ventricular tachycardia in a case with hypertrophic cardiomyopathy taking cibenzoline.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cardiopulmonary Resuscitation; Exe | 2021 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H | 2009 |
Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Australia; Cardiomyopathy, Hypertrophic; Defibrillators, Implant | 2004 |
Case records of the Massachusetts General Hospital. Case 26-2005. A 48-year-old man with sudden loss of consciousness while jogging.
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardiac; Diagnosis, Differentia | 2005 |
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyop | 2007 |
Cardiomyopathy secondary to sinus tachycardia.
Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Sotalol; Tachycardia, Sinus | 1993 |
Cardiac memory: a mechanical and electrical phenomenon.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Cardiomyopathy, Hypertrophic; | 1997 |
Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Combined Modality Therapy; Defibrillators, Implanta | 2002 |
[Therapeutic indications for sotalol 160 mg].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dil | 1985 |